A new drug application (NDA) has been submitted to the FDA for sunvozertinib in pretreated EGFR exon 20–positive advanced non ...
NextCure is going all in on its preclinical B7-H4-directed antibody-drug conjugate (ADC). | NextCure is going all in on its ...
The following is a summary of “Perioperative chemotherapy and nivolumab in non-small-cell lung cancer (NADIM): 5-year ...
Aumolertinib showed improved PFS in NSCLC and ivonescimab outperforms pembrolizumab in advanced cases. Plus, insights into CAR T-cell therapy and its associated AEs are discussed in relapsed multiple ...
Perioperative chemoimmunotherapy for resectable non-small cell lung cancer (NSCLC) shows promising long-term benefits with ...
Updated findings from the phase 3 ENGOT-cx11/GOG-3047/KEYNOTE-A18 study (NCT04221945) show the survival advantages of ...
“We are proud of the progress made in the third quarter of 2024 to advance our investigational allogeneic cell products in key “firsts ... of ALLO-316 following standard FC (fludarabine (30 mg/m2) and ...
Three Phase 3 Trials of Datopotamab Deruxtecan-Based Combinations Initiated in Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer ...
Announced encouraging initial Phase 2 data of BDTX-1535 in patients with recurrent EGFRm NSCLC with a broad spectrum of classical, non-classical, and C797S resistance mutations in September 2024 ...
The Manual on MSN2h
Low-cholesterol diet made simple: Dos and don’ts to followHere's a great starter guide to a low-cholesterol diet with a sample meal plan. The post Low-cholesterol diet made simple: ...
The CFTR protein reaches the cell membrane but the channel does not ... or placebo for 28 days Part 1 Group 1 (n = 4) VX-770 25 mg twice daily, then VX-770 75 mg twice daily Group 2 (n = 4 ...
Absci has a long and expensive path to traverse before it can prove the merits of its approach though. Its cash burn is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback